Balentine LLC’s Crocs CROX Stock Holding History

Balentine LLC’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,118	Closed	-$305K	–	266
2024 Q1	$305K	Buy	+2,118	New	+$241K	0.01%	397

Other funds holding CROX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WPA

WIT Partners Advisory Singapore $342M AUM 8.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Balentine LLC's CROX Position: Q2 2024 in Review

Balentine LLC sold out of Crocs (CROX) in Q2 2024, closing a stake of 2,118 shares — an estimated $305K sold.

Balentine LLC first reported a position in CROX in Q1 2024 and held it in 1 quarter. The position peaked at $305K in Q1 2024. 522 funds tracked by Wall St. Rank hold CROX as of Q2 2024.

Balentine LLC reported no remaining Crocs position as of Q2 2024 after selling out during the quarter.
Balentine LLC sold 2,118 Crocs shares in Q2 2024, an estimated $305K.
Balentine LLC first reported a position in Crocs in Q1 2024 and held it in 1 quarter.
Balentine LLC's Crocs position peaked at $305K in Q1 2024.
522 funds tracked by Wall St. Rank held Crocs as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.